Transforming Growth Factor-β1 Released from the Spleen Exerts a Growth Inhibitory Effect on Liver Regeneration in Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transforming Growth Factor-β1 Released from the Spleen Exerts a Growth Inhibitory Effect on Liver Regeneration in Rats

Published:2003-11 Issue:11 Volume:83 Page:1595-1603
ISSN:0023-6837
Container-title:Laboratory Investigation
language:
Short-container-title:Lab Invest

Author:

Ueda Shuhei,Yamanoi Akira,Hishikawa Yoshitaka,Dhar Dipok Kumar,Tachibana Mitsuo,Nagasue Naofumi

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference50 articles.

1. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1

2. The cell biology of transforming growth factor β

3. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.

4. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors of portal hypertensive enteropathy exacerbations based on long-term outcomes;BMC Gastroenterology;2024-08-26

2. Molecular Pathways Governing the Termination of Liver Regeneration;Pharmacological Reviews;2024-03-04

3. Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding;World Journal of Gastrointestinal Surgery;2023-08-27

4. Splenectomy and azygoportal disconnection decreases the risk of hepatocellular carcinoma for cirrhosis patients with portal hypertension bleeding: a 10-year retrospective follow-up study based on the inverse probability of treatment weighting method;Journal of Gastroenterology;2023-03-21

5. Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension;Frontiers in Immunology;2022-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3